Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Aristotle University Of Thessaloniki University of Athens |
---|---|
Information provided by: | Aristotle University Of Thessaloniki |
ClinicalTrials.gov Identifier: | NCT00306176 |
The aim of the present study is to investigate the influence of systemic exercise, rosiglitazone administration and combined pharmaceutical and lifestyle intervention on cardiovascular risk factors
Condition | Intervention | Phase |
---|---|---|
Type II Diabetes Mellitus |
Drug: Rosiglitazone |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus |
Ages Eligible for Study: | 40 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Greece | |
AHEPA University Hospital of Thessaloniki | |
Thessaloniki, Greece, 54454 |
Study Chair: | Christos Liapis, PhD,MD | University of Athens,Greece |
Study ID Numbers: | 1975 |
Study First Received: | March 22, 2006 |
Last Updated: | April 3, 2007 |
ClinicalTrials.gov Identifier: | NCT00306176 |
Health Authority: | Greece: National Organization of Medicines |
rosiglitazone,exercise,cardiovascular risk factors |
Metabolic Diseases Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases |
Endocrinopathy Metabolic disorder Glucose Metabolism Disorders Rosiglitazone |
Hypoglycemic Agents Physiological Effects of Drugs Pharmacologic Actions |